复杂性区域疼痛综合征患者的肠道微生物组组成与功能改变
本研究比较了53例复杂性区域疼痛综合征(CRPS)患者与52名年龄、性别和种族匹配的无痛对照者的肠道微生物组,采用16S rRNA基因扩增和靶向代谢组学分析粪便与血浆。结果显示CRPS患者多种细菌分类群 abundance 存在显著差异,包括短链脂肪酸代谢菌种,且粪便和血浆短链脂肪酸水平不同。微生物组组成单独即可在独立地理测试队列中准确分类患者与对照。
要点
- CRPS患者肠道微生物组组成与功能存在独特改变,涉及短链脂肪酸代谢。
- 粪便和血浆短链脂肪酸水平在CRPS患者与对照间存在差异。
- 微生物组组成可准确区分CRPS患者与对照,提示潜在诊断价值。
核心结论
- CRPS个体肠道微生物组存在独特的组成和功能变化,支持肠道微生物组在慢性疼痛综合征中的作用。
研究设计与样本
- 比较53例CRPS患者与52名年龄、性别和种族匹配的无痛对照者的肠道微生物组,使用16S rRNA基因扩增,参与者来自两个地理独立区域。
- 进行粪便和血浆靶向代谢组学分析,并训练机器学习算法识别CRPS特异性微生物组组成,在验证队列中测试。
主要发现
- 差异丰度分析显示53例CRPS患者与52名无关对照间多个细菌分类群存在显著差异,包括短链脂肪酸代谢菌种改变。
- 靶向粪便和血浆代谢物分析证实CRPS患者与对照间粪便和血浆短链脂肪酸水平存在差异。
- 微生物组组成单独即可在地理独立的测试队列中准确分类患者与对照。
临床怎么用
- 肠道微生物组组成和短链脂肪酸代谢变化可能作为CRPS诊断辅助和未来治疗靶点,但需进一步研究验证。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complex regional pain syndrome is a chronic pain syndrome typically affecting a limb. It is characterized by severe spontaneous and evoked pain, along with vasomotor, autonomic, and motor signs and symptoms. Although dysregulation in several physiologic systems has been suggested in complex regional pain syndrome (CRPS), including aberrant inflammatory and immune responses, vasomotor dysfunction, and nervous system changes, the pathophysiologic mechanisms underlying the syndrome remain elusive. Effective treatment options are also limited. Previous research has highlighted the role of the gut microbiome in chronic pain, prompting us to investigate the composition and function of the gut microbiome in CRPS. METHODS: The gut microbiomes of individuals with CRPS to age-, sex-, and ethnicity-matched pain-free control participants were compared using 16S rRNA gene amplification. To minimize environmental confounders, participants were recruited from two geographically independent regions. To explore potential changes in gut bacteria-derived metabolites, targeted metabolomic analysis of feces and plasma was performed. Finally, machine learning algorithms were trained to identify the gut microbiome composition specific to CRPS patients and were tested on a validation cohort. RESULTS: In this study, differential abundance analysis revealed significant differences in several bacterial taxa when comparing 53 CRPS patients to 52 unrelated controls, including alterations in short-chain fatty acid-metabolizing species. Targeted stool and plasma metabolite analysis confirmed differences in fecal and plasma short-chain fatty acid levels between CRPS patients and controls. Notably, the microbiome composition alone allowed accurate classification of patients and controls in a geographically independent test cohort. CONCLUSIONS: These findings highlight unique compositional and functional changes in the gut microbiome of individuals with CRPS, thus contributing to the growing body of evidence supporting the role of the gut microbiome in chronic pain syndromes. Furthermore, they pave the way for further studies elucidating the pathophysiology of CRPS and exploring new diagnostic aids and treatment modalities.
引用
- Gonzalez E, Sahar T, Haddad M, et al. Altered Gut Microbiome Composition and Function in Individuals with Complex Regional Pain Syndrome. Anesthesiology. 2025. PMID: 40042519. doi:10.1097/ALN.0000000000005435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。